AUSTRALIAN PRODUCT RECALL

Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL

Published 14 January 2022

Product

Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL Batch numbers: 12636, 12639, 12868, 13057, 13061, 13260, 13510, 13626, 13969, 13971, 15338, 15344, 16265, 16375 and 16470 Supplied via Special Access Scheme (SAS)

Why it was recalled

The Lidocaine Hydrochloride topical solution can become stronger than intended.

Hazard

An increased dose of Lidocaine could lead to the development of local anaesthetic toxicity and this may result in serious adverse health effects.

Read the official notice ↗

Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.